CRP and chronic obstructive pulmonary disease: One of the best systemic biomarkers used to distinguish between the stable disease and exacerbation (Hurst et al. 2006) is a systemic biomarker of acute inflammation, plasma C‐reactive protein (CRP), which is elevated in the circulation of patients with exacerbated COPD (Dev et al. 1998).